December 21, 2009

HighRes Biosolutions, the leader in laboratory automation solutions for life science, announced today that industry veteran Andy Zaayenga has been hired as Director of Business Development. Andy’s appointment accompanies a period of consistent expansion for HighRes, including new offerings in sample management and increasing focus in biospecimen science.

June 22, 2009

HighRes Biosolutions, the leader in innovative robotic systems and laboratory devices for private and academic research laboratories, announced the launch of NanoCell, its newest entry into the world of modular robotic equipment used in drug discovery. NanoCell, the smallest modular work cell available, responds to the ever-increasing demand for a small, flexible, and dynamic system that can do all that HighRes’ larger MicroStar can do - but over a smaller footprint and on a much smaller budget.

September 2, 2008

(La Jolla, CA) - September 2, 2008 - Burnham Institute for Medical Research (Burnham) announced today that it has been awarded a prestigious six-year, $97.9 million Molecular Libraries Probe Production Centers Network (MLPCN) grant from the National Institutes of Health (NIH). Burnham will equip and manage one of four comprehensive small-molecule screening and discovery centers in the nation. Burnham was selected from among some of the nation’s largest and most prestigious universities and medical research institutions.

May 6, 2008

FAST growing US life science automation company, HighRes Biosolutions, is expanding into Europe and is opening an office in the UK. HighRes, which was only formed a few years ago, is already the leading automation integrator for the pharmaceutical sector in the US and is busy developing a large suite of laboratory instruments.

August 20, 2007

Woburn, MA August 20, 2007 – High Resolution Engineering has just signed a major contract to supply the Burnham Institute for Medical Research (Burnham) with specialized equipment for storing and screening large biological libraries. To be installed at the Institute’s Lake Nona, Orlando campus, the new three-pod system, the largest of its kind in the industry will fortify Burnham’s bi-coastal research and drug discovery efforts, which include research on cancer, neurological diseases, aging, diabetes, and obesity, as well as other diseases.